← All Sponsors
SPONSOR

Second Hospital of Shanxi Medical University

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Extensive-stage Small-cell Lung Cancer
NCT06536868 Phase 2
Recruiting

Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC

Extensive-stage Small-cell Lung Cancer
China View Trial →